Clinical Trial News Archive - May 2025

May 1, 2025

HHS, NIH Launch Next-Generation Universal Vaccine Platform for Pandemic-Prone Viruses

May 2, 2025

FDA Accepts Filing Application for Oral Semaglutide 25 mg, Which If Approved, Would Be The First Oral GLP-1 Treatment for Obesity

May 5, 2025

Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy
Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Chamber Trial of Reproxalap and Plans NDA Resubmission

May 6, 2025

Boehringer Ingelheim Starts Phase II Study of BI 1584862, Potential First-in-Class Oral Compound as a Treatment for Geographic Atrophy

May 7, 2025

Final Data From the Phase 3 MYR301 Study Demonstrated Longer Treatment With Bulevirtide Was Associated With Sustaining Undetectability After Stopping Treatment

May 8, 2025

GLISTEN Phase III Trial Results Show Linerixibat Significantly Improves Cholestatic Pruritus in Primary Biliary Cholangitis

May 9, 2025

May 11, 2025

Zepbound (tirzepatide) Showed Superior Weight Loss Over Wegovy (semaglutide) in Complete SURMOUNT-5 Results Published in The New England Journal of Medicine

May 13, 2025

In New SELECT Trial Analysis, Early Reduction in Cardiovascular Events Was Observed with Wegovy®, Before Clinically Meaningful Changes in Body Weight

May 14, 2025

The New England Journal of Medicine Publishes Data from Phase 2b Trial of Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) in People with Narcolepsy Type 1

May 15, 2025

Infant with Carbamoyl Phosphate Synthetase 1 (CPS1) Deficiency First to Successfully Receive Personalized Gene Therapy Treatment

May 19, 2025

May 20, 2025

Global Phase III Trials Demonstrate That Nerandomilast Slowed Lung Function Decline in IPF and PPF, with Similar Discontinuation Rates to Placebo

Clinical trial results archive

2025: January, February, March, April, May
2024: January, February, March, April, May, June, July, August, September, October, November, December
2023: January, February, March, April, May, June, July, August, September, October, November, December
2022: January, February, March, April, May, June, July, August, September, October, November, December
2021: January, February, March, April, May, June, July, August, September, October, November, December
2020: January, February, March, April, May, June, July, August, September, October, November, December
2019: January, February, March, April, May, June, July, August, September, October, November, December
2018: January, February, March, April, May, June, July, August, September, October, November, December
2017: May, June, July, August, September, October, November, December
2016: October

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Recently Approved

Emrelis
Emrelis (telisotuzumab vedotin) is a first-in-class, c-Met protein directed...
Avmapki Fakzynja Co-Pack
Avmapki Fakzynja Co-Pack (avutometinib and defactinib, co-packaged) is a kinase...
Atzumi
Atzumi (dihydroergotamine mesylate) is a nasal powder formulation of the...

More drug approvals